✦ LIBER ✦

Flosequinan as a third agent for the treatment of hypertension: A placebo controlled, double-blind study

✍ Scribed by A. J. Cowley; R. D. Wynne; J. R. Hampton

Book ID: 104799751
Publisher: Springer
Year: 1987
Tongue: English
Weight: 171 KB
Volume: 33
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00544568

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glutathione as an oral whitening agent:

Glutathione as an oral whitening agent: A randomized, double-blind, placebo-controlled study

✍ Arjinpathana, Nutthavuth; Asawanonda, Pravit 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 277 KB

Zolpidem “as needed” for the treatment o

Zolpidem “as needed” for the treatment of primary insomnia: A double-blind, placebo-controlled study

✍ James K. Walsh 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 534 KB

Feverfew (Tanacetum parthenium) as a pro

Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind placebo-controlled study

✍ D. Palevitch; G. Earon; R. Carasso 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

To assess the effectiveness of feverfew as a prophylactic therapy for migraine, a double-blind placebo controlled cross-over trial was conducted for a period of 4 months. Fifty seven patients who attended an outpatient pain clinic were selected at random and divided into two groups. Both groups were

Cibenzoline for treatment of ventricular

Cibenzoline for treatment of ventricular arrhythmias: A double-blind placebo-controlled study

✍ John B. Kostis; Susan Krieger; Abel Moreyra; Nora Cosgrove 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 583 KB

A Double-Blind, Randomized, Placebo-Cont

A Double-Blind, Randomized, Placebo-Controlled Study of Quetiapine as Adjunctive Treatment for Adolescent Mania

✍ DELBELLO, MELISSA P.; SCHWIERS, MICHAEL L.; ROSENBERG, H. LEE; STRAKOWSKI, STEPH 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Candicidin treatment of prostatism: A pr

Candicidin treatment of prostatism: A prospective double-blind placebo-controlled study

✍ Jensen, K. M.-E. ;Madsen, P. O. 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 385 KB

The polyene macrolide candicidin was investigated in the treatment of benign prostatic hyperplasia (BPH). Forty-one unselected patients with BPH and prostatism were admitted to a prospective, double-blind placebo-controlled clinical trial. Patients treated with 270 mg candicidin daily for 6 months h